Local Resistance to Oxidative Stress by Overexpression of Copper-Zinc Superoxide Dismutase Limits Neointimal Formation after Angioplasty

Abstract

Purpose:

To examine the effects of oxidative stress on neointimal hyperplasia through local overexpression of human copper-zinc superoxide dismutase (Cu-Zn SOD).

Methods:

The left common femoral arteries (CFA) of 18 New Zealand white rabbits were subjected to balloon overdilation injury. Each dilated CFA was then incubated with either a nonviral (buffer) or viral (adenovirus overexpressing β-galactosidase) control or an adenovirus overexpressing Cu-Zn SOD. Animals were then sacrificed at 3, 7, or 28 days (3 arteries per group per time point) and the treated CFA segments were harvested for analysis of esterase-positive inflammatory cells and extracellular matrix elements. The intima-to-media ratio (I/M) was measured to assess the degree of neointimal formation.

Results:

At 3 days, local SOD levels in the Cu-Zn SOD—treated group were significantly elevated relative to both controls (p<0.01). Significant reductions in lipid peroxidation byproducts were also seen in the SOD group relative to viral and nonviral controls (p<0.05). Mean I/M at 28 days was 0.582±0.088 for the nonviral control group versus 0.565±0.133 for the viral control group. The SOD-treated group had a significant reduction relative to both controls: 0.259±0.045 (p<0.05). Statistically significant reductions in I/M were also demonstrated in the SOD group relative to control groups at 7 days (p<0.05). The SOD-treated group demonstrated significant preservation of elastin relative to controls, as well as a significant reduction in esterase-positive granulocytes relative to controls (p<0.05).

Conclusions:

Direct buffering of oxidative stress in balloon-injured vessels can significantly alter postinjury response and limit neointimal hyperplasia.

Keywords

restenosis atherosclerosis antioxidants inflammation free radicals lipid peroxidation rabbit model extracellular matrix smooth muscle cells superoxide dismutase

Get full access to this article

View all access options for this article.

References

Yokoi

Daida

Kuwabara

. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: The Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol. 1997; 30: 855–862.

Tardif

Cote

Lesperance

. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med. 1997; 337: 365–372.

Anderson

Meredith

Yeung

. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995; 332: 488–493.

Freyschuss

Stiko-Rahm

Swedenborg

. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest. 1993; 91: 1282–1288.

Schneider

Berk

Gravanis

. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation. 1993; 88: 628–637.

Edelman

. Vessel size, antioxidants, and restenosis: Never too small, not too little, but often too late. Circulation. 1998; 97: 416–420.

Ross

. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999; 340: 115–126.

Weidinger

McLenachan

Cybulsky

. Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation. 1990; 81: 1667–1679.

Handin

Karabin

Boxer

. Enhancement of platelet function by superoxide anion. J Clin Invest. 1977; 59: 959–965.

10.

Salvemini

de Nucci

Sneddon

. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol. 1989; 97: 1145–1150.

11.

Mittal

Murad

. Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: A physiological regulator of guanosine 3′,5′-monophosphate formation. Proc Natl Acad Sci USA. 1977; 74: 4360–4364.

12.

Katusic

Vanhoutte

. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol. 1989; 257: H33–37.

13.

Beckman

Crow

. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans. 1993; 21: 330–334.

14.

White

Brock

Chang

. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 1994; 91: 1044–1048.

15.

Lynch

Frei

Morrow

. Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol. 1997; 17: 2975–2981.

16.

Fang

Weintraub

Rios

. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ Res. 1998; 82: 1289–1297.

17.

Cherry

Omar

Farrell

. Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am J Physiol. 1990; 259: H1056–1062.

18.

Miles

Bohle

Glassbrenner

. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem. 1996; 271: 40–47.

19.

Gibbons

Dzau

. Molecular therapies for vascular diseases. Science. 1996; 272: 689–693.

20.

Kunsch

Medford

. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999; 85: 753–766.

21.

Lusis

. Atherosclerosis. Nature. 2000; 407: 233–241.

22.

Southorn

Powis

. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc. 1988; 63: 381–389.

23.

Laurindo

da Luz

Uint

. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation. 1991; 83: 1705–1715.

24.

Libby

Ganz

. Restenosis revisited—new targets, new therapies. N Engl J Med. 1997; 337: 418–419.

25.

Williams

Kus

Tanda

. Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody. Br J Pharmacol. 1994; 111: 1123–1128.

26.

Satriano

Shuldiner

Hora

. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest. 1993; 92: 1564–1571.

27.

Suh

Arnold

Lassegue

. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 1999; 401: 79–82.

28.

Collins

Read

Neish

. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995; 9: 899–909.

29.

Barnes

Karin

. Nuclear factor-kappa B: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336: 1066–1071.

30.

Ward

Mulligan

. Leukocyte oxygen products and tissue damage. In: Jesaitis

Dratz

, eds. Molecular Basis of Oxidation Damage by Leukocytes. Boca Raton, FL: CRC Press; 1992: 139–149.

31.

Marumo

Schini-Kerth

Fisslthaler

. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappa B and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation. 1997; 96: 2361–2367.

32.

Marui

Offermann

Swerlick

. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993; 92: 1866–1874.

33.

Stiko

Regnstrom

Shah

. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler Thromb Vasc Biol. 1996; 16: 194–200.

34.

Violaris

Melkert

Herrman

. Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty: A quantitative angiographic analysis. Circulation. 1996; 93: 889–897.

35.

Miller

Gutterman

Rios

. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998; 82: 1298–1305.

36.

Ghadge

Lee

Bindokas

. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection. J Neurosci. 1997; 17: 8756–8766.

37.

Waugh

Li-Hawkins

Yuksel

. Thrombomodulin overexpression to limit neointima formation. Circulation. 2000; 102: 332–337.

38.

Waugh

Kattash

. Gene therapy to promote thromboresistance: Local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model. Proc Natl Acad Sci USA. 1999; 96: 1065–1070.

39.

Leite

Danilovic

Moriel

. Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits. Arterioscler Thromb Vasc Biol. 2003; 23: 2197–2202.

40.

Welt

Edelman

Simon

. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol. 2000; 20: 2553–2558.

41.

Thompson

Rabinovitch

. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor. J Cell Physiol. 1996; 166: 495–505.

42.

Senior

Griffin

Mecham

. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol. 1984; 99: 870–874.

43.

Bendeck

Zempo

Clowes

. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994; 75: 539–545.

44.

Ooyama

Fukuda

Oda

. Substratum-bound elastin peptide inhibits aortic smooth muscle cell migration in vitro. Arteriosclerosis. 1987; 7: 593–598.

45.

Strauss

Chisholm

Keeley

. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994; 75: 650–658.

46.

Huang

Feng

Oldham

. Superoxide dismutase as a target for the selective killing of cancer cells. Nature. 2000; 407: 390–395.

47.

Laukkanen

Kivelä

Rissanen

. Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation. 2002; 106: 1999–2003.